ClinicalTrials.Veeva

Menu

Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy

O

Ondokuz Mayıs University

Status

Completed

Conditions

Duchenne Muscular Dystrophy (DMD)

Treatments

Other: Peabody Developmental Motor Scales-2, PDMS

Study type

Observational

Funder types

Other

Identifiers

NCT05990608
2021/371

Details and patient eligibility

About

To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).

Enrollment

48 patients

Sex

All

Ages

3 to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • for Group I:

    • No neurodevelopmental problems or diseases
    • 3-5 years old
    • Being able to cooperate with the instructions given by the physiotherapist.
    • Children who volunteered to participate in the study and whose families gave consent form will be included in the study.
  • for Group II:

    • Being diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist
    • 3-5 years old
    • Children who volunteered to participate in the study and whose parents' consent was obtained will be included in the study.

Exclusion criteria

  • Children with a behavioral condition and any disorder that interferes with testing (eg autism spectrum disorder)
  • Failure to cooperate with the physiotherapist who made the evaluations.
  • Lack of volunteers.

Trial design

48 participants in 2 patient groups

Group I
Description:
Healthy Children
Treatment:
Other: Peabody Developmental Motor Scales-2, PDMS
Group II
Description:
Children with DMD
Treatment:
Other: Peabody Developmental Motor Scales-2, PDMS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems